Because of remarkable decrease in androgen and increase in SHBG concentrations, hyperandrogenemic PCOS phenotype patients may have greater benefits and antiandrogenic progestins are preferred in patients with this phenotype. The gene discussed is SHBG; the disease is polycystic ovary syndrome.